ghk-cu clinical trial skin anti-aging randomized Epigenetic mechanisms activated by increase collagen density in Reducing Redness & Inflammation with
Description
[DOI] [PubMed] [Google Scholar] 29.World Health Organization
[PubMed: 2161554] 242
And he's the guy that Wired magazine, I think way back in 2013, originally did the article on
Clinical trial data from the SURMOUNT-1 study showed that gastrointestinal adverse events were significantly more common during dose escalation periods (Jastreboff et al., 2022, NEJM)
leaky gut syndrome as a catch-all diagnosis is debated
